Study of a Smart Sharps Disposal Device in Patients With Hemophilia

This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.

Preventative factor or non-factor product IV administration has been shown to improve outcomes in patients with hemophilia. The need for patients to log their doses or complete questionnaires can be burdensome. This study seeks to use novel technology, a smart sharps container that records disposal of the needle used to administer preventive products. We will perform a prospective study of adult patients with hemophilia A/B who are on factor or non-factor products. They will all be given the device to take home and use there.

Inclusion: * Male or female, ≥18 years of age * Moderate or Severe Hemophilia A or B, with or without an inhibitor * Prescribed prophylaxis with either a factor product or emicizumab that is scheduled to be given at least once every 14 days Exclusion: * Stated inability to use the SharpsCue container * Treatment with another investigational drug or other intervention during the study period * Patients on prophylactic dosing less than once every 14 days * Patients who are infused by a home nurse